3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
4
Plasma cell
2
Myeloid
2
Lymphoid
2
Gastrointestinal
2
Thoracic
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Endocrine
1
Dermatologic
1
Classical hematology
1
CNS
1
Breast
1
Conditions
Carcinoma, Non-Small-Cell Lung
10
Colorectal Neoplasms
4
Ovarian Neoplasms
3
Neoplasms
3
Melanoma
3
Lung Neoplasms
3
Neoplasms by Site
2
Gastrointestinal Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Thyroid Cancer, Papillary
1
Thoracic Neoplasms
1
Skin Neoplasms
1
Respiratory Tract Neoplasms
1
Respiratory Tract Diseases
1
Pancreatic Neoplasms
1
Noonan Syndrome
1
Neoplasms, Squamous Cell
1
Neoplasms by Histologic Type
1
Multiple Myeloma
1
Lung Diseases
1
Laryngeal Neoplasms
1
Hematologic Neoplasms
1
Glioma
1
Glioblastoma
1
Erdheim-Chester Disease
1
Cholangiocarcinoma
1
Interventions
Nivolumab
3
trametinib
2
pertuzumab
2
dabrafenib
2
binimetinib
2
Trastuzumab
2
Azacitidine
2
ulixertinib
1
trastuzumab biosimilar HLX02
1
tazemetostat
1
sapanisertib
1
romidepsin
1
ribociclib
1
relatlimab
1
palbociclib
1
osimertinib
1
omipalisib
1
margetuximab
1
larotrectinib
1
itacitinib
1
ipatasertib
1
erdafitinib
1
defactinib
1
copanlisib
1
cobimetinib
1
cc-486
1
capivasertib
1
bintrafusp alfa protein, human
1
adavosertib
1
X-Rays
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hematologic Neoplasms
×
cobimetinib
×
Thoracic
×
Clear all
NCT05768178
2025-11-24
DETERMINE
Cancer Research UK
Phase 2/3
Recruiting
30 enrolled